Patents by Inventor Mike Frodsham

Mike Frodsham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID DOSAGE FORMS WITH IMPROVED DISINTEGRATION PROFILES
    Publication number: 20230190831
    Abstract: Methods and compositions related to improved solid dosage forms (e.g., minitablets) that facilitate the oral delivery of bacteria or agents of bacterial origin are provided herein.
    Type: Application
    Filed: April 16, 2021
    Publication date: June 22, 2023
    Inventors: Syed Altaf, Mike Frodsham, James Graves, Jiannan Lu, Lance Pryce
  • In vitro method for determining the adsorbing capacity of an insoluble adsorbant
    Patent number: 11549878
    Abstract: The invention relates to an in vitro method for determining the adsorbing capacity of an adsorbent having limited solubility, such as a bile acid sequestrant, under conditions simulating the mammalian gastrointestinal tract. The method is particularly useful for studying the release profiles of controlled release formulations comprising adsorbents having limited solubility.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: January 10, 2023
    Assignee: Albireo AB
    Inventors: Per-Göran Gillberg, Anna-Maria Tivert, Mike Frodsham, Jamie Farrar
  • Compositions
    Patent number: 10980748
    Abstract: There is provided a solid pharmaceutical composition for delivering by oral administration a pharmaceutically active binding polypeptide to a region of the intestinal tract comprising a compressed core, wherein the compressed core comprises a pharmaceutically active binding polypeptide and wherein the compressed core is coated with a pH sensitive enteric coating.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: April 20, 2021
    Assignee: VHsquared Ltd.
    Inventors: Scott Crowe, Mike West, Kevin Roberts, Tim Carlton, Luana Maggiore, Marion Cubitt, Gary Whale, John Wahlich, Mike Frodsham
  • COMPOSITIONS
    Publication number: 20200368167
    Abstract: There is provided a solid pharmaceutical composition for delivering by oral administration a pharmaceutically active binding polypeptide to a region of the intestinal tract comprising a compressed core, wherein the compressed core comprises a pharmaceutically active binding polypeptide and wherein the compressed core is coated with a pH sensitive enteric coating.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Inventors: Scott Crowe, Mike West, Kevin Roberts, Tim Carlton, Luana Maggiore, Marion Cubitt, Gary Whale, John Wahlich, Mike Frodsham
  • Compositions
    Patent number: 10772839
    Abstract: There is provided a solid pharmaceutical composition for delivering by oral administration a pharmaceutically active binding polypeptide to a region of the intestinal tract comprising a compressed core, wherein the compressed core comprises a pharmaceutically active binding polypeptide and wherein the compressed core is coated with a pH sensitive enteric coating.
    Type: Grant
    Filed: September 25, 2018
    Date of Patent: September 15, 2020
    Assignee: VHsquared Limited
    Inventors: Scott Crowe, Mike West, Kevin Roberts, Tim Carlton, Luana Maggiore, Marion Cubitt, Gary Whale, John Wahlich, Mike Frodsham
  • IN VITRO METHOD FOR DETERMINING THE ADSORBING CAPACITY OF AN INSOLUBLE ADSORBANT
    Publication number: 20200049611
    Abstract: The invention relates to an in vitro method for determining the adsorbing capacity of an adsorbent having limited solubility, such as a bile acid sequestrant, under conditions simulating the mammalian gastrointestinal tract. The method is particularly useful for studying the release profiles of controlled release formulations comprising adsorbents having limited solubility.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 13, 2020
    Inventors: Per-Göran Gillberg, Anna-Maria Tivert, Mike Frodsham, Jamie Farrar
  • COMPOSITIONS
    Publication number: 20190008778
    Abstract: There is provided a solid pharmaceutical composition for delivering by oral administration a pharmaceutically active binding polypeptide to a region of the intestinal tract comprising a compressed core, wherein the compressed core comprises a pharmaceutically active binding polypeptide and wherein the compressed core is coated with a pH sensitive enteric coating.
    Type: Application
    Filed: September 25, 2018
    Publication date: January 10, 2019
    Applicant: VHSQUARED LIMITED
    Inventors: Scott Crowe, Mike West, Kevin Roberts, Tim Carlton, Luana Maggiore, Marion Cubitt, Gary Whale, John Wahlich, Mike Frodsham